Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Raslová

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|February 1, 1995
[Patient education in the metabolic syndrome]B Krahulec, K Raslová
Physiological Research|January 1, 1995
Dyslipoproteinaemia in children with or without family history of premature myocardial infarctionK Raslová, M Hucková
Vnitrni Lekarstvi|April 1, 1995
[Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia]K Raslová, M Hucková
Physiological Research|November 6, 1998
Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrateA Nagyová, K Raslová, E Ginter
Physiological Research|September 13, 2000
Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndromeA Nagyová, M Sustrová, K Raslová
Casopis Lekaru Ceskych|March 8, 1993
[Diagnosis of primary hyperlipoproteinemia during a preventive examination]K Raslová, V Mongiellová, M Hucková
European Journal of Clinical Pharmacology|January 1, 1997
Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemiaK Raslová, D Dubovská, V Mongiellová, et al.
Bratislavske Lekarske Listy|January 1, 1985
[The importance of apolipoprotein B determination in familial hyperlipoproteinemia]S Oravec, K Raslová, P Kolesár, et al.
Bratislavske Lekarske Listy|May 1, 1985
[The effect of genetic factors on blood lipoprotein levels]K Raslová, S Oravec, P Kolesár, et al.
Vnitrni Lekarstvi|June 1, 1986
[Apolipoprotein A-I and high-density lipoprotein cholesterol in familial hyperlipoproteinemias]K Raslová, S Oravec, P Kolesár, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|February 1, 1995
[Patient education in the metabolic syndrome]B Krahulec, K Raslová
Physiological Research|January 1, 1995
Dyslipoproteinaemia in children with or without family history of premature myocardial infarctionK Raslová, M Hucková
Vnitrni Lekarstvi|April 1, 1995
[Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia]K Raslová, M Hucková
Physiological Research|November 6, 1998
Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrateA Nagyová, K Raslová, E Ginter
Physiological Research|September 13, 2000
Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndromeA Nagyová, M Sustrová, K Raslová
Casopis Lekaru Ceskych|March 8, 1993
[Diagnosis of primary hyperlipoproteinemia during a preventive examination]K Raslová, V Mongiellová, M Hucková
European Journal of Clinical Pharmacology|January 1, 1997
Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemiaK Raslová, D Dubovská, V Mongiellová, et al.
Bratislavske Lekarske Listy|January 1, 1985
[The importance of apolipoprotein B determination in familial hyperlipoproteinemia]S Oravec, K Raslová, P Kolesár, et al.
Bratislavske Lekarske Listy|May 1, 1985
[The effect of genetic factors on blood lipoprotein levels]K Raslová, S Oravec, P Kolesár, et al.
Vnitrni Lekarstvi|June 1, 1986
[Apolipoprotein A-I and high-density lipoprotein cholesterol in familial hyperlipoproteinemias]K Raslová, S Oravec, P Kolesár, et al.
Pageof 3